BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34967554)

  • 21. Upregulation of long noncoding RNA ANRIL correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Cao T; Shen J; Pan W; Li C; Qiao Z
    J BUON; 2018; 23(6):1862-1866. PubMed ID: 30610814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
    Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
    Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
    [No Abstract]   [Full Text] [Related]  

  • 25. Long non‑coding RNA LINC00460 serves as a potential biomarker and oncogene via regulation of the miR‑320b/PBX3 axis in acute myeloid leukemia.
    Zhuang Q; Jin Z; Zheng X; Jin T; Xiang L
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients.
    Izadifard M; Pashaiefar H; Yaghmaie M; Montazeri M; Sadraie M; Momeny M; Jalili M; Ahmadvand M; Ghaffari SH; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
    Genet Test Mol Biomarkers; 2018 Oct; 22(10):593-598. PubMed ID: 30222365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of the long non-coding RNAs "CCAT1, PVT1" in t(8;21) associated Acute Myeloid Leukemia.
    El-Khazragy N; Elayat W; Matbouly S; Seliman S; Sami A; Safwat G; Diab A
    Gene; 2019 Jul; 707():172-177. PubMed ID: 30943439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
    Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia.
    El-Khazragy N; Ghozy S; Matbouly S; Zaki W; Safwat G; Hussien G; Khalifa O
    J Cell Biochem; 2019 Sep; 120(9):15288-15296. PubMed ID: 31038787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
    Hao S; Shao Z
    Int J Clin Exp Pathol; 2015; 8(6):7223-8. PubMed ID: 26261618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA
    Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
    Tang P; Xie M; Wei Y; Xie X; Chen D; Jiang Z
    Med Sci Monit; 2019 Jul; 25():4999-5004. PubMed ID: 31278736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of plasma bone marrow Activin-A and CXCL-12 concentration levels as a biomarker in acute myeloid leukemia.
    Aref S; Ebrahim L; El-Ashwah S; El Agdar M; Ayed M
    Cancer Biomark; 2021; 32(3):263-270. PubMed ID: 34092614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.
    Damm F; Oberacker T; Thol F; Surdziel E; Wagner K; Chaturvedi A; Morgan M; Bomm K; Göhring G; Lübbert M; Kanz L; Fiedler W; Schlegelberger B; Heil G; Schlenk RF; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Feb; 29(6):682-9. PubMed ID: 21205756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
    Wang Y
    Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC).
    Xie F; Huang Q; Wang C; Chen S; Liu C; Lin X; Lv X; Wang C
    Cancer Biomark; 2020; 27(3):357-364. PubMed ID: 31929143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.